Onderzoek naar de kosten en werkzaamheid van injectiekuren (immunotherapie) bij patiënten met een allergie voor boompollen, graspollen en/of huisstofmijt.
Recruiting
- Conditions
- EN:allergic rhinitisimmunotherapyadultcosts and cost analysesNL:allergische rhinitisimmunotherapievolwassenenkosten-effectiviteit
- Registration Number
- NL-OMON25681
- Lead Sponsor
- Erasmus MC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 240
Inclusion Criteria
1. 18-45 years;
2. Clinically relevant moderate to severe allergic rhinitis due to a sensitization for one, two or three of the following
allergens: tree pollen (TP), grass pollen (GP) and/or house dust mite (HDM). For each allergen (TP, GP, HDM) the following 3 criteria are evaluated. A sensitization for an allergen is considered clinically relevant and the rhinitis moderate-severe if:
Exclusion Criteria
1. Severe/instable asthma:
A. FEV1 <70% predicted and/or FEV1/FVC <70;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method